Отдельные психоактивные вещества

Источник:
Клиническая фармакология по Гудману и Гилману том 1.
Редактор: профессор А.Г. Гилман Изд.: Практика, 2006 год.

Отдельные психоактивные веществаПравить

Содержимое статьи удалено по требованию Роскомнадзора.

ЛитератураПравить

Alterman, A.I., O’Brien, С.P., McLellan, А.Т., August, D.S., Snider, E.C., Droba, М., Cornish, J.W., Hall, C.P., Raphaelson, A.H., and Shrade, F.X. Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. J. Nerv. Ment. Dis., 1994, 182:157—163.
Anthony, J.C., Warner, L.A., and Kessler, K.C. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and the inhalants: basic findings from the national comorbidity survey. Exp. Clin. Psychopharmacol., 1994, 2:244—268.
Balster, R.L., Johanson, C.E., Harris, R.T., and Schuster, C.R. Phencyclidine self-administration in the rhesus monkey. Pharmacol. Biochem. Behav., 1973, 1:167-172.
Benowitz, N.L., Porchet, H., Sheiner, L., and Jacob, P. III. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin. Pharmacol. Ther., 1988, 44: 23-28.
Chasnoff, I.J., Griffith, D.R., MacGregor, S., Dirkes, K., and Bums, K.A. Temporal patterns of cocaine use in pregnancy. Perinatal outcome. JAMA, 1989, 261:1741-1744.
Devane, W.A., Dysarz, F.A. Ill, Johnson, M.R., Melvin, L.S., and Howlett, A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 1988, 34:605—613.
Higgins, S.T., Budney, A.J., Bickel, W.K., Foerg, F.E., Ogden, D., and Badger, G.J. Outpatient behavioral treatment for cocaine dependence: one-year outcome. Presented at College on Problems of Drug Dependence Symposium, 1994.
Martin, W.R., and Jasinski, D.R. Psychological parameters of morphine in man: tolerance, early abstinence, protracted abstinence. J. Psychiatr. Res., 1969, 7:9-17.
Marzuk, P.M., Tardiff, K., Leon, A.C., Hiisch, C.S., Stajic, М., Porte-ra, L., Hartwell, N., and Iqbal, M.I. Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N. Engl. J. Med., 1995, 332:1753-1757.
Mendelson, J.H., and Mello, N.K. Medical progress. Biologic concomitants of alcoholism. N. Engl. J. Med., 1979, 301:912—921.
O’Brien, C.P. A range of research-based pharmacotherapies for addiction. Science, 1997, 278:66—70.
Robinson G.M., Sellers, E.M., and Janecek, E. Barbiturate and hyp-nosedative withdrawal by a multiple oral phenobarbital loading dose technique. Clin. Pharmacol. Then, 1981, 30:71—76.
Russell, M.A.H. Nicotine intake and its regulation by smokers. In, Advances in Behavioral Biology. Vol. 31. Tobacco Smoking and Nicotine. (Martin, W.R., Van Loon, G.R., Iwamoto, E.T., and Davis, L., eds.) New York, Plenum Press, 1987, pp. 25—31.
Satel, S.L., Southwick, S.M., and Gawin, F.H. Clinical features of cocaine-induced paranoia. Am. J. Psychiatry, 1991, 148:495—498.
Silverman, К., Evans, S.M., Strain, E.C., and Griffith, R.R. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N. Engl. J. Med., 1992, 327:1109-1114.
Trujillo, K.A., and Akil, H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 1991, 251:85-87.
Vfolkow, N.D., Wang, G.L., Fowler, J.S., Logan, J., Gatley, S.J., Wong, C., Hitzemann, R.,and Pappas, N.R. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors. J. Pharmacol. Exp. Then, 1999,291:409—415.
Wjddington, W.W., Brown, B.S., Haertzen, C.A., Cone, E.J., Dax, E.M., Heming, R.I., and Michaelson, B.S. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch. Gen. Psychiatry, 1990,47:861—868.